| Application no. and date | 99922459.5 (espacenet) (Federated) (European Patent Register), 19990614 | | Patent/reg. no. and date | DK/EP 1100499, 20040310 | | Publication date | 20010523 | | Priority no. and date | GB 9816556, 19980730 | | EP pub. no. and date |
EP 1100499 20010523 | | Effective date | | | Applicant/owner | PFIZER INC., 235 East 42nd Street
New York, N.Y. 10017, US | | Applicant ref. no. | P200400318 EP DK | | Inventor | JACKSON, Neville, Colin, Pfizer Central Research,
Ramsgate Road
Sandwich,
Kent CT13 9NJ, GB,
UDEN, Stephen, Pfizer Central Research,
Ramsgate Road
Sandwich,
Kent CT13 9NJ, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/41, A61K 31/42, A61K 31/445, A61P 25/06, A61K 31/40 | | Title | Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse | | Int. application no. | IB1999001105 | | Int. publication no. | WO2000006161 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
